Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Early omicron breakthroughs show mRNA vaccines’ weakness

Booster shots with messenger RNA vaccines such as those made by Pfizer Inc. and BioNTech SE failed to block omicron in a study of some of the first documented breakthrough cases caused by the highly contagious variant.

Tribune News Service

Pfizer CEO awarded $1M Genesis Prize for developing COVID vaccine

Albert Bourla is recognised for being at the forefront of fighting the pandemic and developing a vaccine in record time.

Al Jazeera

Pfizer's COVID-19 Oral Antiviral Shows In-Vitro Efficacy Against Omicron Variant

Pfizer Inc (NYSE: PFE) yesterday

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Booster shots offer ‘much better protection’ against symptomatic COVID-19

There is good evidence that booster shots offer much greater protection against symptomatic disease, serious disease and death.

The New Daily

Pfizer chief Albert Bourla wins $1 million Genesis Prize

Pfizer's chief executive, Albert Bourla, has been awarded the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine

The Independent UK

Four doses not enough to stop omicron

Omicron's vaccine-resistant properties have prompted Pfizer to start work on an omicron-specific vaccine

Salon

Should I mix or match my booster? Your COVID-19 vaccine questions answered

For many Australians, it’s now time for a COVID booster – but which one should you be getting? Read our handy guide to find out.

ABC News

Read news from The Economist, FT, and more,
with one subscription

Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal

Novasep

Benzinga

FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis

Along with AbbVie Inc's (NYSE: ABBV)

Benzinga

Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed

Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults.

Benzinga

Macron Touts Rosy French Economy, New Jobs Ahead of Election

President Emmanuel Macron on Monday touted 21 new foreign investment projects in France and a booming economy as proof his economic reforms have been bearing fruit less than three months before a presidential election in which he is expected to run. During a visit to Alsace in the east, Macron…

Asharq Al-Awsat

Why getting boosted is a pain in the arm

Have you had "Pfizer boob" after COVID booster?

Newcastle Herald

Israeli Study Shows 4th Shot of COVID-19 Vaccine Less Effective on Omicron

A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a preliminary study in Israel. Israel's Sheba Medical Center has given second booster shots in a trial among its staff and is studying…

Asharq Al-Awsat

Latest COVID updates: Canada approves Pfizer COVID pill

COVID news from January 17: Canada authorises pill for adults with mild, moderate COVID who are at high risk.

Al Jazeera

Get all your
news in one place.

100's of premium titles.
One news app.

1 … 69 70 71 72

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.